EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic Haematocrit for Myocardial Extracellular Volume Mapping in Clinical Practice at 1.5 T and 3 T

Elif Ayduk Gövdeli, Mohamed Elzoghby, Teresa Maria Capovilla, Daniele Muser, Gianfranco Sinagra, Gaetano Nucifora

Diagnostics · 13.11.2026 · 16 (22) · 3760

DOI: 10.3390/diagnostics16223760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 13.11.2026. Verfasst von Elif Ayduk Gövdeli und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Synthetic haematocrit (HCT) permits cardiovascular magnetic resonance (CMR) extracellular volume fraction (ECV) estimation without contemporaneous laboratory HCT. We evaluated four published equations in a clinical referral cohort.

Methods

This retrospective audit included 67 adults scanned at 1.5 T (n = 34) or 3 T (n = 33), with laboratory HCT within 24 h. Two equations per field strength were assessed using correlation and Bland–Altman analysis with confidence intervals. Observer reproducibility of T1 and calculated synthetic ECV was assessed using intraclass correlation coefficients (ICCs). Post hoc exploratory analyses examined classification at ECV ≥ 30%, estimation-error associations and proportional bias.

Results

Absolute mean ECV bias was below one percentage point for all equations, but model-specific limits of agreement extended from −4.47 to 4.19 percentage points. At the exploratory 30% threshold, classification agreement was 85.3% and 88.2% at 1.5 T and 75.8% for both equations at 3 T. Synthetic ECV intraobserver ICCs ranged from 0.853 to 0.949; interobserver ICCs were 0.936–0.944 at 1.5 T and 0.842–0.851 at 3 T. Shang HCT showed magnitude-dependent disagreement.

Conclusions

Synthetic ECV may help assess myocardial tissue when timely laboratory haematocrit is unavailable, with low average differences from conventional ECV. However, the small groups limit precision and generalisability, and individual and observer differences prevent assuming interchangeability. Local validation is needed before using synthetic ECV for clinical decisions or monitoring changes over time.

Zitieren

APA

Gövdeli, E. A., Elzoghby, M., Capovilla, T. M., Muser, D., Sinagra, G., & Nucifora, G. (2026). Synthetic Haematocrit for Myocardial Extracellular Volume Mapping in Clinical Practice at 1.5 T and 3 T. Diagnostics, 16(22), 3760. https://doi.org/10.3390/diagnostics16223760

Vancouver

Gövdeli EA, Elzoghby M, Capovilla TM, Muser D, Sinagra G, Nucifora G. Synthetic Haematocrit for Myocardial Extracellular Volume Mapping in Clinical Practice at 1.5 T and 3 T. Diagnostics. 2026;16(22):3760. doi:10.3390/diagnostics16223760

BibTeX
@article{Gvdeli2026,
  author = {Gövdeli, Elif Ayduk and Elzoghby, Mohamed and Capovilla, Teresa Maria and Muser, Daniele and Sinagra, Gianfranco and Nucifora, Gaetano},
  title = {Synthetic Haematocrit for Myocardial Extracellular Volume Mapping in Clinical Practice at 1.5 T and 3 T},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {3760},
  doi = {10.3390/diagnostics16223760}
}
Kostenlos starten →